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Abstract Hydropathy analysis predicts 11 transmembrane
helices in the cardiac Na+/Ca2+ exchanger. Using cysteine
susceptibility analysis and epitope tagging, we here studied the
membrane topology of the exchanger, in particular of the highly
conserved internal K-1 and K-2 repeats. Unexpectedly, we found
that the connecting loop in the K-1 repeat forms a re-entrant
membrane loop with both ends facing the extracellular side and
one residue (Asn-125) being accessible from the inside and that
the region containing the K-2 repeat is mostly accessible from the
cytoplasm. Together with other data, we propose that the
exchanger may consist of nine transmembrane helices.
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1. Introduction
The plasma membrane Na/Ca2 exchanger is an electro-
genic transporter that catalyzes the exchange of three Na for
one Ca2. It is involved primarily in the extrusion of Ca2
from the cytoplasm, although it may mediate Ca2 in£ux
under some conditions. The mammalian Na/Ca2 exchanger
forms a multigene family of three isoforms NCX1, NCX2 and
NCX3, which share V70% identity in overall amino acid
sequences [1^3]. On the basis of the hydropathy analysis,
the mature exchanger protein is modeled to consist of 11
transmembrane helices (TMs) and a large central hydrophilic
loop between TM5 and TM6 [4]. Interestingly, Na/Ca2 ex-
change occurs almost normally in a mutant exchanger deleted
for the large central loop, indicating that the transmembrane
domain alone is su⁄cient to catalyze ion transport [5,6]. The
large central loop is involved in the regulation of the exchang-
er by intracellular cations [7], phosphatidylinositol 4,5-bis-
phosphate [8] and protein phosphorylation [6,9]. Thus, this
loop is exposed on the cytoplasm.
Recent studies have provided evidence that the N-terminus
of the exchanger is localized on the extracellular side of the
plasma membrane, while the C-terminus and the loop con-
necting TM1-TM2 are exposed to the cytoplasm [10,11].
Strikingly, all members of the Na/Ca2 exchanger family
and the Na/Ca2/K exchangers have highly conserved in-
ternal repeat sequences designated the K-1 and K-2 repeats
[4,12], which are modeled to comprise most of the sequences
in TM2-TM3 and TM8-TM9 and the loops connecting these
transmembrane helices (see Fig. 3A). Mutation of amino acid
residues within the putative transmembrane helices of K-1 and
K-2 repeats results in a large reduction of the exchange activ-
ity or a change in the I-V relationship in NCX1 [4], suggesting
the functional importance of these conserved regions. At
present, however, little is known about the structure/function
relationship in the transmembrane domain of the exchanger
molecule.
In this study, using cysteine susceptibility analysis [13] and
c-myc epitope tagging, we studied the membrane topology of
the NCX1 polypeptide, with a particular focus on the internal
K-1 and K-2 repeats. We here provide evidence that the con-
necting loop in the K-1 repeat forms a pore loop-like struc-
ture, whereas the K-2 repeat region may form a domain ex-
posed on the cytoplasmic surface. Our data suggest that the
exchanger is comprized of nine TMs. This novel information
on the exchanger topology will give a new insight into the
structural basis of the exchanger function.
2. Materials and methods
2.1. Cell cultures
CCL39 cells (American Type Culture Collection) and NCX1 trans-
fectants were maintained in Dulbecco’s modi¢ed Eagle’s medium sup-
plemented with 7.5% heat-inactivated fetal calf serum, 50 U/ml pen-
icillin and 50 Wg/ml streptomycin.
2.2. Construction and stable expression of cysteine-substituted or
epitope-tagged NCX1
cDNA of dog heart NCX1.1 was cloned into the mammalian ex-
pression vector pKCRH using SacII-HindIII sites (designated
pKCRH-NCX1) [9]. Substitution of each amino acid residue by cys-
teine and insertion of an epitope peptide sequence were achieved by
site-directed mutagenesis as described [6]. Brie£y, two DNA fragments
were produced by PCR using Pfu polymerase and two pairs of outer
and inner primers, with inner primers containing an overlapping se-
quence with the same desired mutation or with an additional epitope
peptide sequence. The ¢nal PCR products were generated with these
DNA fragments as templates using two outer primers. For mutations
in amino acids 1^530, the primers corresponding to a 5P non-coding
region (sense) and nucleotides 1730^1750 (antisense) were used,
whereas for mutation in amino acids 534^938 the primers correspond-
ing to nucleotides 1690^1710 (sense) and a 3P non-coding region (anti-
sense) were used. After digestion with restriction enzymes, the ¢nal
PCR products were inserted into pKCRH-NCX1. For the construc-
tion of epitope-tagged exchangers, the human c-myc epitope (EQKLI-
SEEDLN) was inserted between Pro-31 and Gln-32 in the N-terminal
portion or between Phe-938 and the stop codon in the C-terminal
portion (designated Myc-NT or Myc-CT, respectively). Successful
construction was veri¢ed by sequencing (ABI PRISM, Perkin-Elmer).
pKCRH plasmids were transfected into CCL39 cells using Lipofectin
(Gibco BRL) and stable cell clones exhibiting high Na/Ca2 ex-
change activity were selected by ionomycin treatment (Ca2 killing)
[14].
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2.3. Assay of intracellular Na+ (Na+i)-dependent 45Ca
2+ uptake
For cell Na loading, con£uent cells in 24 well dishes were incu-
bated at 37‡C for 30 min in 0.5 ml of BSS (146 mM NaCl, 4 mM
KCl, 2 mM MgCl2, 0.1 mM CaCl2, 10 mM glucose and 10 mM
HEPES/Tris (pH 7.4)) containing 1 mM ouabain and 10 WM mon-
ensin. Cells were treated with 10 mM membrane impermeant SH
labelling reagent (2-(trimethylammonium)ethyl)methanethiosulfonate
bromide (MTSET) (Toronto Research Chemicals) during the last 10
min of cell Na loading and then washed three times. The rate of
Na i-dependent 45Ca2 uptake into cells was measured for 30 s as
described previously [15]. The rate of uptake into cells pretreated with
MTSET was normalized to that into untreated control cells and ex-
pressed as percentage of the latter (Fig. 1).
2.4. Measurement of whole cell exchange currents
Exchange currents from transfectants were measured using the
whole cell voltage clamp technique as described [16]. Outward and
inward currents were elicited employing a standard square step volt-
age protocol [17], in which membranes were depolarized from a hold-
ing potential of 330 mV to +60 mV for 500 ms followed by hyper-
polarization to 380 mV for 500 ms. This protocol was repeated at
every 20 s for 6^10 min. The bath solution contained 140 mM Na
glutamate, 1 mM MgCl2, 1.8 mM CaCl2, 0 or 5 mM NiSO4, 20 WM
ouabain, 2 WM verapamil, 0 or 1 mM MTSET and 5 mM HEPES
(pH 7.4). The pipette solution contained 120 mM CsOH, 6 mM
MgCl2, 7 mM CaCl2, 5 mM Na2ATP, 50 mM aspartic acid, 5 mM
creatine phosphate, 20 mM EGTA, 20 mM tetraethylammonium
chloride, 0 or 10 mM MTSET and 20 mM HEPES (pH 7.2). Control
and MTSET inhibitable exchange currents were estimated as Ni2-
sensitive charge movements that were quanti¢ed by integrating Ni2-
sensitive outward currents recorded with or without MTSET. The
Ni2-sensitive current was never observed in non-transfected cells
(data not shown). Control and MTSET-blocked outward currents
were measured in the same cell. To examine the e¡ect of internally
applied MTSET, the control current was monitored initially within 15
s after rupturing the cell membrane and then the MTSET-blocked
current was monitored after the current reached a steady state in
V6 min. Ni2 was subsequently applied to the bath to estimate the
Ni2-insensitive charge movement, which was subtracted from the
control or MTSET-blocked one. For the e¡ect of externally applied
MTSET, the exchange current was measured before or V6 min after
placing cells in a bath solution containing 1 mM MTSET. The Ni2-
sensitive charge movement measured with MTSET was normalized to
the Ni2-sensitive control charge movement and expressed as percent-
age of the latter (Fig. 1). As the time-matched control, we performed
similar experiments without MTSET in the pipette or bath solution.
We found no signi¢cant change in the currents using this protocol. All
experiments were performed at about 34‡C. Data were acquired and
analyzed by the pCLAMP (Axon Instrument) software.
2.5. Immuno£uorescence
For permeabilization, cells were ¢xed in BSS containing 4% para-
formaldehyde for 5 min at 25‡C and then permeabilized in BSS con-
taining 0.5% Triton X-100 for 5 min at 25‡C. Intact cells and per-
meabilized cells were incubated with anti-c-myc monoclonal antibody
(9E10, Genosys) (1:50) for 0.5 h at 37‡C and 3 h at 25‡C, respectively,
in BSS containing 5% BSA. These cells were subsequently washed ¢ve
times with the same medium and then treated with FITC-conjugated
donkey anti-mouse IgG (Cappel) (1:500). After three washes, cells
were observed by confocal laser scanning microscopy using a Bio-
Rad MRC-1024 system mounted on an Olympus BX50WI micros-
cope with a plan-apochromat U40 water immersion lens.
2.6. Statistical analysis
Data are expressed as means þ S.E. of three^seven independent de-
terminations. Di¡erences were analyzed by unpaired t-test. Values of
P6 0.05 were considered statistically signi¢cant.
3. Results and discussion
On the basis of the hydropathy analysis and available ex-
perimental evidence, the mature Na/Ca2 exchanger protein
has been predicted to consist of 11 TMs with the C-terminus
and the large central hydrophilic loop localized on the intra-
cellular side of the membrane and the N-terminus being on
the extracellular side (see Section 1). Hence, ¢ve and six TMs
are predicted to separate the N-terminus and the large central
loop, and the large central loop and the C-terminus, respec-
tively [4] (see Fig. 3A, 11 TM model).
In this study, we investigated the membrane topology of the
cardiac Na/Ca2 exchanger expressed in CCL39 ¢broblasts
that are devoid of endogenous exchange activity [6,9,14]. To
determine the validity of the 11 TM model, in particular the
topology of the K-1 and K-2 repeat regions, we selected amino
acid residues that are predicted by this model to be near the
surface of the membrane and on the loops connecting TM2-
TM3 and TM8-TM9 and examined their intracellular or ex-
tracellular accessibility using cysteine susceptibility analysis
[13]. In this analysis, targeted residues were individually mu-
tated to cysteine and the inhibition of exchange activity of the
resulting mutants by membrane impermeant SH labelling re-
agent MTSET was assessed. MTSET and its related com-
pounds form an irreversible, covalent bond with the sulfhy-
dryl group in cysteine and have been used successfully in
identifying residues accessible from extracellular and intracel-
lular media in channels and transporters [10,13,18,19].
To assess the accessibility by externally applied MTSET, we
measured the rate of Nai-dependent 45Ca2 uptake into
CCL39 cells expressing cysteine-substituted mutants in the
presence and absence of MTSET. On the other hand, the
accessibility by intracellular MTSET was assessed by measur-
ing the whole cell outward exchange currents from single cells
expressing cysteine-substituted mutants. The activity of each
cysteine-substituted mutant used in this study is shown in Fig.
1 (see relative activity). Some mutants displayed a low uptake
activity, which probably results from a reduced exchange ac-
tivity or reduced synthesis of the mutated proteins.
We found that extracellular or intracellular application of
MTSET exerted little e¡ect on the activity of the wild-type
exchanger (Fig. 1), although the mature exchanger protein
contains 15 endogenous cysteine residues. This result is con-
sistent with the previous observation [10]. On the other hand,
the Leu-102 to Cys mutant (L102C) was inhibited by intra-
cellular but not by extracellular MTSET (Fig. 1), indicating
the intracellular accessibility of this residue. In contrast,
E120C was inhibited by extracellular but not by intracellular
MTSET. The intervening residues Leu-107 and Ser-117 were
inhibited neither by intracellular nor extracellular MTSET.
On the other hand, I136C was inhibited only by extracellular
MTSET, whereas V155C and R161C were inhibited only by
intracellular MTSET. These results are consistent with the 11
TM model which predicts that Leu-102 is localized at the N-
terminal end of TM2, that Leu-107 and Ser-117 are localized
within TM2 and that Ile-136, Val-155 and Arg-161 are local-
ized at the extracellular and cytoplasmic side of TM3, respec-
tively.
We further examined the accessibility of residues in the loop
connecting TM2-TM3. We found that G123C, A128C,
G129C and S134C were inhibited by extracellular MTSET,
indicating that these residues are accessible from the extra-
cellular side (Fig. 1). Ileu-136 at the end of this loop was
also inhibited by extracellular MTSET as described above.
Unexpectedly, however, N125C was inhibited by intracellular
but not by extracellular MTSET. As for the mutants H124C,
T127C and D130C, we did not observe statistically signi¢cant
inhibition by either intracellular or extracellular MTSET. We
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also examined the accessibility of residues in TM8-TM9 and
the loop connecting these putative transmembrane helices.
A802C was inhibited by extracellular but not by intracellular
MTSET (Fig. 1). In contrast, S818C, A821C, D825C, Y827C,
G833C, G837C, N842C and A855C were all inhibited by in-
tracellular but not by extracellular MTSET. Other mutants
L808C, K819C, Q824C, A830C and V835C were not a¡ected
by extracellular MTSET.
We assessed the accessibility of G123C, N125C, A128C and
G833C in the loops connecting TM2-3 and TM8-9 by exam-
ining the e¡ect of extracellular MTSET on the whole cell out-
ward exchange currents from single cells expressing these mu-
tants. The exchange currents from wild-type, G123C, N125C,
A128C and G833C in the presence of extracellular MTSET
were 100 þ 18, 8.8 þ 13*, 116 þ 24, 4.0 þ 1.3* and 135 þ 19% of
the controls measured in the absence of the reagent, respec-
tively (n=3 or 4; *P6 0.05 versus the wild-type). Thus, we
con¢rmed the results obtained from 45Ca2 uptake measure-
ments with these mutants (Fig. 1). These data, together with
those described in the preceding paragraph, suggest that the
FEBS 21686 15-3-99
Fig. 2. Immuno£uorescent staining of cells expressing c-myc epitope-tagged exchangers. Intact cells expressing Myc-NT or Myc-CT and per-
meabilized cells expressing Myc-CT were stained with anti-c-myc antibody 9E10.
Fig. 1. E¡ect of extracellular or intracellular application of MTSET on activities of the wild-type or cysteine-substituted exchangers. The upper
panel shows the e¡ect of extracellular MTSET on the rate of Na i-dependent 45Ca2 uptake measured as described in Section 2.3. The lower
panel shows the e¡ect of intracellular MTSET on the whole cell outward exchange currents measured from three^seven single transfectants as
detailed in Section 2.4. The columns marked with an asterisk are signi¢cantly di¡erent (P6 0.05) from those for the wild-type transfectants.
ND, not determined. Relative activity, uptake activities of transfectant clones are shown: +, 0.5V1 nmol/mg/30 s; ++, 1V3 nmol/mg/30 s;
+++, 3V8 nmol/mg/30 s.
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loop connecting TM2-TM3 forms a re-entrant membrane
loop with both ends facing the extracellular side and Asn-
125 being accessible from the intracellular side (see new model
in Fig. 3B). In contrast, the portion of the exchanger contain-
ing the putative TM8-TM9 and the loop connecting them are
mostly accessible from the cytoplasmic side.
We further examined the location of other putative loops.
S191C and Y892C were modestly, but signi¢cantly, inhibited
by extracellular MTSET, whereas W763C was sensitive to
inhibition only by intracellular MTSET (Fig. 1). H858C and
Q864C were also inhibited only by intracellular MTSET.
These data are consistent with the view that the loop connect-
ing TM4-TM5 in the 11 TM model is accessible from the
extracellular side, while the putative loops connecting TM6-
TM7 and TM9-TM10 are accessible from the cytoplasmic
side. Furthermore, the region immediately C-terminal to
TM10 seems to be located on the extracellular surface.
We assessed the accessibility of the human c-myc epitope
introduced into the N-terminus (Myc-NT) or the C-terminus
(Myc-CT) of the exchanger molecule. Both tagged mutants
expressed in CCL39 cells exhibited high exchange activities
equivalent to that of the wild-type exchanger (data not
shown). As shown in Fig. 2, Myc-NT was stained with anti-
c-myc antibody 9E10 in intact cells, whereas Myc-CT was
detected with the antibody only in permeabilized cells, indi-
cating that the N-terminal and C-terminal portions of the
exchanger are localized on the extracellular and cytoplasmic
surfaces of the membrasne, respectively. This ¢nding is con-
sistent with the previous report [11].
Based on the results described in the preceding paragraphs,
we propose a new topological model of the exchanger mole-
cule consisting of nine TMs as illustrated in Fig. 3B. In
marked contrast to the 11 TM model, the region encompass-
ing Ser-818^Asn-842, which contains most of the K-2 repeat,
is placed on the cytoplasmic side. Unfortunately, however, the
current data alone are not su⁄cient to delineate the structure
of this region. TM6 is also placed on the cytoplasmic side,
because hydrophobicity of this segment is signi¢cantly less
than those of other TMs and because some algorithms for
prediction of transmembrane helices and topology predict it
to be intracellular [11].
Our prediction of topology of the N-terminal half of the
transmembrane domain of the exchanger is similar to that of
the 11 TM model, except that the connecting loop in the K-1
repeat forms a re-entrant membrane loop with both ends fac-
ing the extracellular side and one of the residue (Asn-125)
being readily accessible from the cytoplasm (Fig. 3B). This
latter structure is reminiscent of pore loops from ion channels
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Fig. 3. Topological models of the Na/Ca2 exchanger. A: original 11 TM model. B: new model. The results of cysteine susceptibility analysis
are shown: closed circles, residues accessible only to extracellular MTSET; open circles, residues accessible only to intracellular MTSET. The
positions of c-myc epitope tag are indicated by an open triangle. Open boxes with Arabic numbers are the transmembrane helices previously
modeled on the basis of hydropathy analysis. XIP, exchanger inhibitory peptide region.
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[20]. The glutamate transporter GLT-1 also has a pore loop-
like structure, although the function of this loop is not known
[19]. Recently we have obtained an important clue to the
function of this pore loop-like structure in the Na/Ca2 ex-
changer. We have observed that the divalent cation Ni2, a
competitive inhibitor of transport substrate Ca2, is 10-fold
more inhibitory to NCX1 than to NCX3 [15]. Using chimeras
between NCX1 and NCX3 and site-directed mutagenesis,
Asn-125 and Thr-127 within the loop of the K-1 repeat were
found to be partly responsible for the observed di¡erential
responses of NCX isoforms to Ni2 (T. Iwamoto et al., un-
published observation). Thus, the re-entrant loop in the K-1
repeat could be an important structure involved in the binding
and transport of substrate cations.
Acknowledgements: This work was supported by Grant-in-Aid for
Priority Areas (09273101) and Encouragement of Young Scientists
(10770048) from the Ministry of Education, Science and Culture of
Japan and a grant from the Human Science Research Foundation.
References
[1] Nicoll, D.A., Longoni, S. and Philipson, K.D. (1990) Science
250, 562^565.
[2] Li, Z., Matsuoka, S., Hryshko, L.V., Nicoll, D.A., Bersohn,
M.M., Burke, E.P., Lifton, R.P. and Philipson, K.D. (1994)
J. Biol. Chem. 269, 17434^17439.
[3] Nicoll, D.A., Quednau, B.D., Qui, Z., Xia, Y.-R., Lusis, A.J. and
Philipson, K.D. (1996) J. Biol. Chem. 271, 24914^24921.
[4] Nicoll, D.A., Hryshko, L.V., Matsuoka, S., Frank, J.S. and Phi-
lipson, K.D. (1996) J. Biol. Chem. 271, 13385^13391.
[5] Matsuoka, S., Nicoll, D.A., Reilly, R.F., Hilgeman, D.W. and
Philipson, K.D. (1993) Proc. Natl. Acad. Sci. USA 90, 3870^
3874.
[6] Iwamoto, T., Pan, Y., Nakamura, T.Y., Wakabayashi, S. and
Shigekawa, M. (1998) Biochemistry 37, 17230^17238.
[7] Hilgemann, D.W. (1996) Ann. New York Acad. Sci. 779, 136^
158.
[8] Hilgemann, D.W. and Ball, R. (1996) Science 273, 956^959.
[9] Iwamoto, T., Pan, Y., Wakabayashi, S., Imagawa, T., Yamana-
ka, H.I. and Shigekawa, M. (1996) J. Biol. Chem. 271, 13609^
13615.
[10] Doering, A.E., Nicoll, D.A., Lu, Y., Lu, L., Weiss, J.N. and
Philipson, K.D. (1998) J. Biol. Chem. 273, 778^783.
[11] Cook, O., Low, W. and Rahamimo¡, H. (1988) Biochim. Bio-
phys. Acta 1371, 40^52.
[12] Schwarz, E.M. and Benzer, S. (1997) Proc. Natl. Acad. Sci. USA
94, 10249^10254.
[13] Akabas, M.H., Stau¡er, D.A., Xu, M. and Karlin, A. (1992)
Science 258, 307^310.
[14] Iwamoto, T., Wakabayashi, S., Imagawa, T. and Shigekawa, M.
(1998) Eur. J. Cell Biol. 76, 228^236.
[15] Iwamoto, T. and Shigekawa, M. (1998) Am. J. Physiol. 275,
C423^C430.
[16] Uehara, A., Iwamoto, T., Shigekawa, M. and Imanaga, I. (1997)
Pfuºgers Arch. 434, 335^338.
[17] Haddock, P.S., Coetzee, W.A. and Artman, M. (1997) Am.
J. Physiol. 273, H837^846.
[18] Fu, D., Ballesteros, J.A., Weinstein, H., Chen, J. and Javitch,
J.A. (1996) Biochemistry 35, 11278^11285.
[19] Grunewald, M., Bendahan, A. and Kanner, B.I. (1998) Neuron
21, 623^632.
[20] MacKinnon, R. (1995) Neuron 14, 889^892.
FEBS 21686 15-3-99
T. Iwamoto et al./FEBS Letters 446 (1999) 264^268268
